<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02295553</url>
  </required_header>
  <id_info>
    <org_study_id>1000036780</org_study_id>
    <nct_id>NCT02295553</nct_id>
  </id_info>
  <brief_title>Ketamine and Propofol for Upper Endoscopy</brief_title>
  <official_title>Co-administration of Ketamine and Propofol for Upper Endoscopy in Children: a Dose-finding Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the dose-response relationship of ketamine in
      combination with propofol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Direct visualization of the esophagus, stomach and small intestine is performed using a scope
      that is inserted while the patient is under under deep sedation or general anesthesia. The
      most common method of providing general anesthesia for upper endoscopy is intravenous
      administration of medications such as propofol, often in combination with other medications
      such as fentanyl, midazolam, remifentanil or ketamine. One study found that the combination
      of propofol and ketamine provides better conditions (less patient movement, more stable heart
      and breathing) but more side effects afterwards compared to propofol and fentanyl.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2013</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Movement (response)/no movement (no response) upon insertion of endoscope into the patient's esophagus</measure>
    <time_frame>From the time of insertion of the endoscope into the patient's mouth until endoscope enters the esophagus</time_frame>
    <description>The objective is to determine the effective bolus dose in 50% of subjects (ED50) of propofol in combination with ketamine 0, 0.25, 0.5 and 1 mg/kg that produces an adequate depth of anesthesia to prevent minimal or no movement on endoscope insertion in children</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of apnea after propofol administration</measure>
    <time_frame>From the time propofol is administered until the time endoscopy is complete</time_frame>
    <description>The patient will be observed for apnea after propofol is administered until the endoscopy procedure is complete. Duration of apnea will be recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse respiratory events during the procedure</measure>
    <time_frame>From induction of anesthesia until endoscopy procedure is complete</time_frame>
    <description>Any respiratory adverse event including desaturation &lt;95 requiring oxygen administration or need for airway management maneuvers (jaw thrust, bag/mask ventilation) to relieve upper airway obstruction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total propofol dose required to complete the procedure</measure>
    <time_frame>From the time first dose of propofol is administered until the end of the procedure</time_frame>
    <description>For each subject, once the response/no response to endoscope insertion has been determined, additional intravenous doses of propofol 0.5 mg/kg may be given at the discretion of the attending anesthesiologist.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of side effects and complications during the recovery period</measure>
    <time_frame>From the time procedure is complete until discharge from hospital with an average time of 1 hour.</time_frame>
    <description>Side effects including:
hallucinations and/or emergence delirium measured by the Pediatric Anesthesia Emergence Delirium (PAED) scale dizziness nausea and/or vomiting administration of antiemetic pain &gt; 3/10 at any site (measured using age appropriate scale) time to discharge readiness using established criteria reasons for delayed discharge (if any)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">56</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Ketamine 0 mg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketamine dose will be 0 mg/kg. Propofol dose for the first patient will be 4 mg/kg. Doses for the subsequent patients will increase or decrease by 1.6 mg/kg using the Dixon Up and Down method.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine 0.25 mg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketamine dose will be 0.25 mg/kg. Propofol dose for the first patient will be 3 mg/kg. Doses for the subsequent patients will increase or decrease by 1.2 mg/kg using the Dixon Up and Down method.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine 0.5 mg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketamine dose will be 0.5 mg/kg. Propofol dose for the first patient will be 2.5 mg/kg. Doses for the subsequent patients will increase or decrease by 0.8 mg/kg using the Dixon Up and Down method.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine 1.0 mg/kg</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ketamine dose will be 1.0 mg/kg. Propofol dose for the first patient will be 2 mg/kg. Doses for the subsequent patients will increase or decrease by 0.4 mg/kg using the Dixon Up and Down method.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <arm_group_label>Ketamine 0.25 mg/kg</arm_group_label>
    <arm_group_label>Ketamine 0.5 mg/kg</arm_group_label>
    <arm_group_label>Ketamine 1.0 mg/kg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <arm_group_label>Ketamine 0 mg/kg</arm_group_label>
    <arm_group_label>Ketamine 0.25 mg/kg</arm_group_label>
    <arm_group_label>Ketamine 0.5 mg/kg</arm_group_label>
    <arm_group_label>Ketamine 1.0 mg/kg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 3-13 years

          -  Receiving general anesthesia for upper endoscopy

        Exclusion Criteria:

          -  Known or possible difficult airway

          -  BMI &gt; 35

          -  Weight &lt; 10 kg

          -  Sedative premedication required

          -  Known contraindication to ketamine or propofol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>13 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason Hayes</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G 1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 12, 2013</study_first_submitted>
  <study_first_submitted_qc>November 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2014</study_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hospital for Sick Children</investigator_affiliation>
    <investigator_full_name>Jason Hayes</investigator_full_name>
    <investigator_title>Staff Anaesthesiologist</investigator_title>
  </responsible_party>
  <keyword>Ketamine</keyword>
  <keyword>Propofol</keyword>
  <keyword>Children</keyword>
  <keyword>Pediatrics</keyword>
  <keyword>Upper endoscopy</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>November 6, 2017</submitted>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

